Outlook remains promising
The over-riding feature of the Interim results from Marshall of Cambridge Holdings (MCH) was the...
Read more
Yet another string to Destiny's bow
Destiny Pharma have always had a microbiome tilt with their most advanced product, topical XF-73,...
Read moreBrand strength reaps rewards
Better than expected sales revenue and profits, substantial growth in the online business, robust...
Read more
Strong start to H2 as demand returns
COVID-19 has impacted businesses in many different ways. However for specialist high speed...
Read moreUnderlying trading strength pays dividends
Cake Box has started FY2021 positively with strong same store sales growth, new store openings and...
Read moreSuccessfully navigating choppy seas
The interims to end June 2020 reveal operational resilience in a challenging period: 99% collection...
Read moreStrong Program growth, healthy Legacy pipeline
In our detailed note on July 7th that followed the 2019 results we argued that R&Q’s shares were...
Read moreCautious optimism
The H1 pre-close trading update from Northbridge suggests that H1 adj. PBT is likely to be broadly...
Read moreTrading update on 6 months to 31 July
In a Trading Update for the six months to 31 July 2020 Checkit reports that, on a normalised basis,...
Read more
Register to be first
Get research on the companies that interest you straight to your inbox
